Publicaciones

  • Sangro, B., C. Gomez-Martin, M. de la Mata, M. Inarrairaegui, E. Garralda, P. Barrera, J. I. Riezu-Boj, E. Larrea, C. Alfaro, P. Sarobe, J. J. Lasarte, J. L. Perez-Gracia, I. Melero, and J. Prieto. 2013. A clinical trial of CTLA-4 blockade with tremelimumab in patients with hepatocellular carcinoma and chronic hepatitis C. J Hepatol 59:81-88. IF (2012): 9.858; Lugar: 5/73 Gastroenterology and Hepatology; 1er cuartil.

  • Morales-Kastresana, A., M. F. Sanmamed, I. Rodriguez, A. Palazon, I. Martinez-Forero, S. Labiano, S. Hervas-Stubbs, B. Sangro, C. Ochoa, A. Rouzaut, A. Azpilikueta, E. Bolanos, M. Jure-Kunkel, I. Gutgemann, and I. Melero. 2013. Combined immunostimulatory monoclonal antibodies extend survival in an aggressive transgenic hepatocellular carcinoma mouse model. Clin Cancer Res 19:6151-6162. IF (2012): 7.837; Lugar: 12/197 Oncology; 1er cuartil.
    ABSTRACT CORTESÍA DE PUBMED

  • Fioravanti, J., I. Gonzalez, J. Medina-Echeverz, E. Larrea, N. Ardaiz, G. Gonzalez-Aseguinolaza, J. Prieto, and P. Berraondo. 2011. Anchoring interferon alpha to apolipoprotein A-I reduces hematological toxicity while enhancing immunostimulatory properties. Hepatology 53:1864-1873. IF (2011): 11.665; Lugar: 2/73 Gastro- enterology and Hepatology; 1er cuartil. 
    ABSTRACT CORTESÍA DE PUBMED

  • Palazon, A., A. Teijeira, I. Martinez-Forero, S. Hervas-Stubbs, C. Roncal, I. Penuelas, J. Dubrot, A. Mo- rales-Kastresana, J. L. Perez-Gracia, M. C. Ochoa, L. Ochoa-Callejero, A. Martinez, A. Luque, J. Dinchuk, A. Rouzaut, M. Jure-Kunkel, and I. Melero. 2011. Agonist anti-CD137 mAb act on tumor endothelial cells to enhance recruitment of activated T lymphocytes. Cancer Res 71:801-811. IF (2011): 7.856; Lugar: 12/196 Oncology; 1er cuartil.
    ABSTRACT CORTESÍA DE PUBMED

  • Casares, N., F. Rudilla, L. Arribillaga, D. Llopiz, J. I. Riezu-Boj, T. Lozano, J. Lopez-Sagaseta, L. Guembe, P. Sarobe, J. Prieto, F. Borras-Cuesta, and J. J. Lasarte. 2010. A peptide inhibitor of FOXP3 impairs regulatory T cell activity and improves vaccine efficacy in mice. J Immunol 185:5150-5159. IF (2010): 5.745; Lugar: 20/134 Immunology; 1er cuartil.
    ABSTRACT CORTESÍA DE PUBMED

  • Riezu-Boj, J. I., E. Larrea, R. Aldabe, L. Guembe, N. Casares, E. Galeano, I. Echeverria, P. Sarobe, I. Herrero, B. Sangro, J. Prieto, and J. J. Lasarte. 2011. Hepatitis C virus induces the expression of CCL17 and CCL22 chemokines that attract regulatory T cells to the site of infection. J Hepatol 54:422-431. IF (2011): 9,334 Gastroenterología y Hepatología Lugar: 4/72 (1Q)

  • Gil-Guerrero, L., J. Dotor, I. L. Huibregtse, N. Casares, A. B. Lopez-Vazquez, F. Rudilla, J. I. Riezu-Boj, J. Lopez-Sagaseta, J. Hermida, S. Van Deventer, J. Bezunartea, D. Llopiz, P. Sarobe, J. Prieto, F. Borras-Cuesta, and J. J. Lasarte. 2008. In vitro and in vivo down-regulation of regulatory T cell activity with a peptide inhibitor of TGF-beta1. J Immunol 181:126-135. IF (2008): 6,068 Inmunología. Lugar: 13/119 (1Q)



"Our team has developed highly promising immune-regulating molecules and vaccination strategies that are being evaluated in clinical trials", Dr. Juan José Lasarte,Program Director.

Contact

Contact:
Cristina López
Avda. Pío XII, 55
31008 Pamplona
Spain

(+34) 948 194 700 Ext. 6021
clopezg@unav.es